Which manufacturing parameters have significant effects on product performance?
In the context of advanced therapeutic medicinal products, the ability to manipulate complex biological mechanisms provides therapy developers with a powerful tool to direct against various diseases.
However, to move forward and establish the true efficacy of cell therapies against specific indications, we must begin to understand which biological variables should be standardised to generate desired therapeutic outcomes.
In this webinar, we consider which manufacturing parameters have significant effects on product performance and suggest potential strategies to mitigate variability. There will also be a discussion on the following:
- Minimising variability in cell manufacture
- The variability within the industry, such as groups manufacturing their own reagents and the need for potency assays
- The considerations for ancillary materials and the impact they can have on both process and product
- How should manufacturers evaluate these reagents to minimise variability of the final product?
- The variability of starting materials and hMSCs, how it impacts cell manufacturing and how to mitigate
Francesco Dazzi, Professor of Regenerative and Haematological Medicine, King's College London
Steven Thompson, VP Sales and Product Management, Sexton Biotechnologies
Scott Jones, VP Scientific Affairs, BioBridge Global
Date: May 27th 2020
Time: 4pm BST | 11am EST | 8am PST
How: register here
The webinar will be available on-demand so if you can't make the live session, register your details and we'll send you the recording.